The sympathetic nervous system and baroreflexes in hypertension and hypotension

Current Hypertension Reports

Volumn 1, Issue 3, 1999, Pages 254-263

  Izzo Jr , Joseph L ^a   Taylor, Addison A ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC SYSTEM; ANIMAL; BRAIN CORTEX; CAROTID BODY; HEART; HEART LEFT VENTRICLE HYPERTROPHY; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPOTENSION; LUNG; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSORECEPTOR REFLEX; REVIEW;

ANIMALS; BAROREFLEX; CAROTID BODY; CEREBRAL CORTEX; HEART; HOMEOSTASIS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; HYPOTENSION; LUNG; SYMPATHETIC NERVOUS SYSTEM;

EID: 0033139858     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-999-0030-9     Document Type: Review

References (76)

1. Abboud FM. The sympathetic system in hypertension. Hypertension 1982, 4(suppl): 208-225.
2. Nathan MA, Reis DJ. Chronic labile hypertension produced by lesions of the nucleus tractus solitarri in the cat. Circ Res 1977, 40: 72-80.
3. Ferrario CM, Barnes KL, Bohonek S. Neurogenic hypertension produced by lesions of the nucleus tractus solitarii alone or with sinoaortic denervation in the dog. Hypertension 1981, 3: 112-118.
4. Bishop VS, Hasser EM, Nair UC. Baroreflex control of renal nerve activity in conscious animals. Circ Res 1987, 61: 76-81.
5. Thames MD, Johnson LN. Impaired cardiopulmonary baroreflex control of renal nerves in renal hypertension. Circ Res 1985, 57: 741-747.
6. Thames MD, Miller BD, Abboud FM. Baroreflex regulation of renal nerve activity during volume expansion. Am J Physiol 1982, 243: 810-814.
7. Guo GB, Abboud FM. Angiotenin II Often Rates Baroreflex Control of Heart Rate and Sympathetic Activity. Am J Physiol 1984, 246:H80-H89. (Pubitemid 14147892)
8. Fink GD, Haywood JR, Bryan WJ, et al. Central site for pressor action of blood-borne angiotensin in rat. Am J Physiol 1980, 239:R358-R361. (Pubitemid 10030359)
9. Hasser EM, Nelson DO, Haywood JR, Bishop VS. Inhibition of renal sympathetic nervous activity by area postrema stimulation in rabbits. Am J Physiol 1987, 253:H91-H99.
10. Cox BF, Bishop VS. Neural and humoral mechanisms of angiotensin-dependent hypertension. Am J Physiol 1991, 261:H1284-H1291.
11. Takeshita A, Imaizumi T, Nakamura N, et al. Attenuation of reflex forearm vasoconstriction by alpha-human atrial natriuretic peptide in men. Circ Res 1987, 61: 555-559.
12. Chapleau MW, Hajduczok G, Abboud FM. Peripheral and central mechanisms of baroreflex resetting [review]. Clin Exp Pharmaco Physiol (suppl) 1989, 15: 31-43.
13. Gribbin B, Pickering TG, Sleight P, Peto R. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 1971, 29: 424-430.
14. Hajduczok G, Chapleau MW, Johnson SL, Abboud FM. Increase in sympathetic activity with age. I. Role of impairment of arterial baroreflexes. Am J Physiol 1991, 260:H1113-H1120.
15. Hajduczok C, Chapleau MW, Abboud FM. Increase in sympathetic activity with age. II. Role of impairment of cardiopulmonary baroreflexes. Am J Physiol 1991, 260:H1121-H1127.
16. Huang BS, Veerasingham SJ, Leenen FH. Brain "ouabain," ANG II, and sympathoexcitation by chronic central sodium loading in rats. Am J Physiol 1998, 274:H1269-H1276.
17. Osterziel KJ, Dietz R, Manthey J, et al. Haemodynamic changes caused by alteration of autonomic activity in patients with heart failure. Brit Heart J 1990, 63: 221-224.
18. Creager MA, Hirsch AT, Dzau VJ, et al. Baroreflex regulation of regional blood flow in congestive heart failure. Am J Physiol 1990, 258:H1409-H1414. (Pubitemid 20187208)
19. Hirsch AT, Dzau VJ, Creager MA. Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance. Circulation 1987, 75 (suppl):IV36-IV48.
20. DiBona GF, Sawin LL. Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. Am J Physiol 1991, 260:R298-R305.
21. Willenbrock R, Stauss H, Scheuermann M, et al. Effect of chronic volume overload on baroreflex control of heart rate and sympathetic nerve activity. Am J Physiol 1997, 273:H2580-H2585.
22. Murakami H, Liu JL, Zucker IH. Angiotensin II blockade enhances baroreflex control of sympathetic outflow in heart failure. Hypertension 1997, 29: 564-569.
23. Osterziel KJ, Röhrig N, Dietz R, et al. Influence of captopril on the arterial baroreceptor reflex in patients with heart failure. Eur Heart J 1988, 9: 1137-1145.
24. Osterziel KJ, Dietz R, Schmid W, et al. ACE inhibition improves vagal reactivity in patients with heart failure. Am Heart J 1990, 120: 1120-1129.
25. Nishian K, Kawashima S, Iwasaki T. Paradoxical forearm vasodilatation and haemodynamic improvement during cardipulmonary baroreceptor unloading in patients with congestive heart failure. Clin Sci 1993; 84: 271-280.
26. Masuo K, Mikami H, Ogihara T, Tuck ML. Differences in insulin and sympathetic responses to glucose ingestion due to family history of hypertension. Am J Hypertens 1996, 9: 739-745.
27. Masuo K, Mikami H, Ogihara T, Tuck ML. Familial hypertension, insulin, sympathetic activity, and blood pressure elevation. Hypertension 1998, 32: 96-100.
28. Court JM, Hill GJ. Hypertension in childhood obesity. Aust Paediatr J 1974, 10: 296-300.
29. Kannel WB, Brand N, Skinner JJ, MacNamera P. The relation of adiposity to blood pressure and development of hypertension: the Framingham study. Ann Intern Med 1976, 67: 48-49.
30. Stamler R, Stamler J, Riedlinger WF, et al. Weight and blood pressure findings in hypertension screening of 1 million Americans. JAMA 1978, 240: 1607-1610.
31. Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation in obese normotensive subjects. Hypertension 1995, 25: 560-563.
32. Gudbjornsdottir S, Lonnroth P, Sverrisdottir YB, et al. Sympathetic nerve activity and insulin in obese normotensive and hypertensive men. Hypertension 1996, 27: 276-280.
33. DeFronzo RA, Ferrannini E. Insulin Resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14(3): 173-194.
34. Sowers JR, Whitfield LA, Catania RA, et al. Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab 1982, 54: 1181-1186.
35. Daly PA, Landsberg L. Hypertension in obesity and NIDDM. Role of insulin and sympathetic nervous system. Diabetes Care 1991, 14(3): 240-248.
36. Facchini FS, Stoohs RA, Reaven GM. Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 1996, 9: 1013-1017.
37. Rowe JW, Young JB, Minaker KL, et al. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981, 30: 219-225.
38. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996, 334: 374-381.
39. Goldstein DS. Plasma catecholamines and essential hypertension: an analytical review. Hypertension 1983, 5: 86-99.
40. Julius S, Krause L, Schork NJ, et al. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens 1991, 9: 77-84.
41. Palantini P, Vriz O, Nesbitt S, et al. Parental hyperdynamic circulation predicts insulin resistance in offspring: the Tecumseh offspring study. Hypertension 1999, 33: 769-774.
42. Hofman A, Boomsma F, Schalekamp MADH, Valkenburg HA. Raised blood pressure and plasma noradrenaline concentrations in teenagers and young adults selected from an open population. Br Med J 1979, 1: 1536-1538.
43. Rand MJ, Majewski H. Adrenaline mediates a positive feedback loop in noradrenergic neurotransmission: its possible role in development of hypertension. Clin Exp Hypertens 1984, A6: 347-370.
44. Messerli FH, Frohlich ED, Suarez DH, et al. Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines. Circulation 1981, 64: 760-764.
45. Izzo JL, Jr., Smith RJ, Larrabee PS, Kallay MC. Plasma norepinephrine and age as determinants of systemic hemodynamics in men with established essential hypertension. Hypertension 1987, 9: 415-419.
46. Izzo JL, Jr. Hypertension in the elderly: A pathophysiologic approach to therapy. J Am Geriatr Soc 1982, 30: 352-359.
47. O'Malley K, Docherty JR, Kelly JG. Adrenoceptor status and cardiovascular function in aging. J Hypertens 1988, 6:(suppl) S59-S62. (Pubitemid 19043898)
48. Ward KD, Sparrow D, Landsberg L, et al. Influence of insulin, sympathetic nervous system activity, and obesity on blood pressure: the Normative Aging Study. J Hypertens 1996, 14: 301-308.
49. Cerasola G, Cottone S, D'Ignoto G, et al. Sympathetic activity in borderline and established hypertension in the elderly. J Hypertens (suppl) 1988, 6:S55-S58. (Pubitemid 19043897)
50. Izzo JL, Jr., Licht MR, Smith RJ, et al. Chronic effects of direct vasodilation (pinacidil), alpha- adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril) in systemic hypertension. Am J Cardiol 1987, 60: 303-308.
51. Esler M, Skews H, Leonard P, et al. Age-dependence of noradrenaline kinetics in normal subjects. Clin Sci 1981, 60: 217-219.
52. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 1989, 14: 177-183.
53. Egan B, Panis R, Hinderliter A, et al. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987, 80: 812-817.
54. Stepniakowski KT, Lu G, Miller GD, Egan BM. Fatty acids, not insulin, modulate alpha1-adrenergic reactivity in dorsal hand veins. Hypertension 1997; 30: 1150-1155.
55. Philipp T, Distler A, Cordes U. Sympathetic nervous system and blood pressure control in essential hypertension. Lancet 1978, 2: 959-963.
56. Zambraski EJ, Ciccone CD, Izzo JL, Jr. The role of the sympathetic nervous system in 2-kidney DOCA-hypertensive Yucatan miniature swine. Clin Exp Hypertens 1986 A8: 411-424.
57. Katholi RE, Winternitz SR, Oparil S. Decrease in peripheral sympathetic nervous system activity following renal denervation or unclipping in the one-kidney one-clip Goldblatt hypertensive rat. J Clin Invest 1982, 69: 55-62.
58. Winternitz SR, Oparil S. Importance of the renal nerves in the pathogenesis of experimental hypertension. Hypertension 1982, 5: 108-114.
59. Dargie HL, Franklin SS, Reid JL. The sympathetic nervous system in renovascular hypertension in the rat. Br J Pharmacol 1976, 56: 365-374.
60. Izzo JL, Jr., Sterns RH. Abnormal norepinephrine release in uremia. Kidney Int 1983, 24(suppl):S221-S223.
61. Converse RL, Jr., Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992, 327: 1912-1918.
62. Axelrod FB, Nachtigal R, Dancis J. Familial dysautonomia: diagnosis, pathogenesis and management. Adv Pediatr 1974, 21: 75-96.
63. Bannister R, Sever P, Gross M. Cardiovascular reflexes and biochemical responses in progressive autonomic failure. Brain 1977, 100: 327-344.
64. Ziegler MG, Lake CR. Autonomic degeneration and altered blood pressure control in humans. Fed Proc 1984, 43: 62-66.
65. Cicogna R, Curnis A, Dei CL, Visioli O. Syncope and tumours in the neck: carotid sinus or glossopharyngeal syndrome? Eur Heart J 1985, 6: 979-984.
66. Lenz ML, Pool JL, Mangoo R, Taylor AA. Identification and management of previously unsuspected carotid sinus hypersensitivity in patients with recurrent syncope or near-syncope [abstract]. Clin Autonom Res 1994, 4:213.
67. Mcintosh SJ, Lawson J, Kenny RA. Clinical characteristics of vasodepressor, cardioinhibitory, and mixed carotid sinus syndrome in the elderly. Am J Med 1993, 95: 203-208.
68. Schellack J, Fulenwider JT, Olson RA, et al. The carotid sinus syndrome: a frequently overlooked cause of syncope in the elderly. J Vasc Surg 1986, 4: 376-383.
69. Strasberg B, Sagie A, Erdman S, et al. Carotid sinus hypersensitivity and the carotid sinus syndrome. Prog Cardiovasc Dis 1989, 31: 379-391.
70. Sugrue DD, Wood DL, McGoon MD. Carotid sinus hypersensitivity and syncope. Mayo Clin Proc 1984, 59: 637-640.
71. Murphy AL, Rowbotham BJ, Boyle RS, et al. Carotid sinus hypersensitivity in elderly nursing home patients. Aust N Z J Med 1986, 16: 24-27.
72. Almquist A, Gornick C, Benson W. Carotid sinus hypersensitivity: evaluation of the vasodepressor component. Circulation 1985, 71: 927-936.
73. Katritsis D, Ward DE, Camm AJ. Can we treat carotid sinus syndrome? Pacing Clin Electrophysiol 1991, 14: 1367-1374.
74. Peretz DI, Abdulla A. Management of cardioinhibitory hypersensitive carotid sinus syncope with permanent cardiac pacing-a seventeen year prospective study. Can J Cardiol 1985, 1: 86-91.
75. Stryjer D, Friedensohn A, Schlesinger Z. Ventricular pacing as the preferable mode for long-term pacing in patients with carotid sinus syncope of the cardioinhibitory type. Pacing Clin Electrophysiol 1986, 9: 705-709.
76. Izzo JL, Jr.: Sympathoadrenal activity, catecholamines, and the pathogenesis of vasculopathic hypertensive target organ damage. Am J Hypertens 1989, 2: 305-312.